Existing users please login

Forgot Password

    Home / Markets / Industries / Health Care

    Thursday, November 19, 2009

    Sanofi-Aventis To Launch Antimalarial Drug Study

    | Respond to Editor | Print

     
    By Sarah Turner
    MarketWatch Pulse
       

      LONDON -- French drugmaker Sanofi-Aaventis and Medicines for Malaria Venture will launch the largest safety and efficacy study of an antimalarial drug. A field-monitoring program on ASAQ, a fixed-dose combination of artesunate and amodiaquine, started in C�te d'Ivoire in October. MMV is a not-for-profit drug research and development organization.

      Copyright © 2009 MarketWatch, Inc.

      Fox Business Video


      Last 5 Stocks

      • Ticker
      • Company
      • Price
      • Change
       

      Personal Finance - Investing - Financial News - Business News - Stock Market Quotes & News - Small Business

      Advertise with us | Jobs at FOX Business Network | Internships at FBN

      Terms of use. Privacy Statement. For FOXBusiness.com technical issues write to foxbusinessonline@foxbusiness.com; for all other feedback, write to feedback@foxbusiness.com.

      Quotes delayed at least 15 minutes. Market Data provided by Interactive Data (Terms & Conditions). Powered and implemented by Interactive Data Managed Solutions. Company fundamental data provided by Morningstar. Earnings estimates data provided by Zacks. Mutual fund data provided by Lipper. Economic data provided by Econoday. Dow Jones & Company Terms & Conditions.

      This material may not be published, broadcast, rewritten, or redistributed. ©2010 FOX News Network, LLC. All rights reserved.